(RTTNews) - While reporting financial results for the fourth quarter on Thursday, Bristol-Myers Squibb Co. (BMY) initiated its adjusted earnings and revenue growth guidance for the full-year 2026, above analysts' estimates.
For fiscal 2026, the company now projects adjusted earnings in a range of about $6.05 to $6.35 per share on worldwide total revenues between about $46.0 billion and $47.5 billion.
On average, 25 analysts polled expect the company to report earnings of $6.04 per share on a revenues decline of 7.85 percent to $44.22 billion for the year. Analysts' estimates typically exclude special items.
In Thursday's pre-market trading, BMY is trading on the NYSE at $58.64, up $1.01 or 1.75 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
